International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in the absence of immunosuppressive drugs and without evidence of rejection are supposed to be exceptional. The ERA-EDTA-DESCARTES working group together with Nantes University launched a European-wide survey to identify new patients, describe them and estimate their frequency for the first time.METHODS: Seventeen coordinators distributed a questionnaire in 256 transplant centres and 28 countries in order to report as many 'operationally tolerant' patients (TOL; defined as having a serum creatinine <1.7 mg/dL and proteinuria <1 g/day or g/g creatinine despite at least 1 year without any immunosuppressive drug) and 'almost tolerant' patients (minim...
Item does not contain fulltextBACKGROUND: Kidney recipients maintaining a prolonged allograft surviv...
Kidney recipients maintaining a prolonged allograft survival in the absence of immunosuppressive dru...
Kidney recipients maintaining a prolonged allograft survival in the absence of immunosuppressive dru...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
Background Kidney recipients maintaining a prolonged allograft survival in the absence of immunosupp...
BACKGROUND: Kidney recipients maintaining a prolonged allograft survival in the absence of immunosup...
BACKGROUND: Kidney recipients maintaining a prolonged allograft survival in the absence of immunosup...
BACKGROUND Kidney recipients maintaining a prolonged allograft survival in the absence of immunos...
Item does not contain fulltextBACKGROUND: Kidney recipients maintaining a prolonged allograft surviv...
Kidney recipients maintaining a prolonged allograft survival in the absence of immunosuppressive dru...
Kidney recipients maintaining a prolonged allograft survival in the absence of immunosuppressive dru...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
International audienceBACKGROUND: Kidney recipients maintaining a prolonged allograft survival in th...
Background Kidney recipients maintaining a prolonged allograft survival in the absence of immunosupp...
BACKGROUND: Kidney recipients maintaining a prolonged allograft survival in the absence of immunosup...
BACKGROUND: Kidney recipients maintaining a prolonged allograft survival in the absence of immunosup...
BACKGROUND Kidney recipients maintaining a prolonged allograft survival in the absence of immunos...
Item does not contain fulltextBACKGROUND: Kidney recipients maintaining a prolonged allograft surviv...
Kidney recipients maintaining a prolonged allograft survival in the absence of immunosuppressive dru...
Kidney recipients maintaining a prolonged allograft survival in the absence of immunosuppressive dru...